Research Article
Liver Transplantation without Perioperative Transfusions Single-Center Experience Showing Better Early Outcome and Shorter Hospital Stay
Table 5
Postoperative outcome following LT in No- and Yes-Transfusion groups.
| | | No Transfusion
| Yes Transfusion
| |
| | PNF (%) | 0 | 1 (1) | 1 | | PDF (%) | 8 (21) | 18 (20) | 1 | | 30 days—arterial thrombosis | 0 | 0 | 1 | | AST peak (U/L)* | 784 (154–17600) | 859 (132–11830) | 0.76 | | ALT peak (U/L)* | 639 (162–4680) | 688 (139–4890) | 0.061 | | ICU stay (days)* | 2 (1–11) | 3 (0–65) | 0.003 | | Hospital stay (days)* | 7.5 (5–21) | 9 (2–105) | 0.01 | | Hospital stay ≥ 15 days (%) | 4 (10) | 24 (27) | 0.03 | | 30-day mortality (%) | 4 (10) | 13 (15) | 0.58 | | Major complication (%) | 7 (18) | 30 (34) | 0.9 | | Hemodialysis need (%) | 0 | 9 (10) | 0.01 | | Bacterial infections (%) | 4 (10) | 24 (27) | 0.03 | | Infections within 30 days (%) | 2 (5) | 19 (22) | 0.02 | | Biliary complications (%) | 3 (8) | 3 (3) | 0.37 | | VHC recurrence (≥F1) (%) | 8 (57) | 9 (50) | 0.68 | | HCC recurrence (%) | 0 | 6 (24) | 0.12 | | 1-year survival % | 86 | 70 | 0.09 | | 3-year survival % | 77 | 66 |
|
|
Median and range; PNF: primary nonfunction; PDF: primary dysfunction; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ICU: intensive care unit; HCV: hepatitis C virus; HCC: hepatocarcinoma.
|
